Medication info

Anapergia Tablet 5/160/10 mg

Prescription medicationApproval withdrawn
Ingredient · strength
Amlodipine Besylate›Strength being verifiedValsartan›Strength being verifiedAtorvastatin Calcium Hydrate›Strength being verified
Manufacturer / importer
Aju Pharmaceuticals Co., Ltd.
Appearance
Light yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202105303 · Approved 2021.07.12

This product's status changed to Approval withdrawn on 2023.09.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
Who uses it
Adults
Adult dosage
Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.

Ingredients

Manufacturer
Aju Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • dyslipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for patients who require the combined administration of amlodipine/valsartan and atorvastatin. The amlodipine/valsartan combination helps lower blood pressure effectively in patients with essential hypertension who have difficulty managing blood pressure with monotherapy. Meanwhile, atorvastatin reduces the risk of various cardiovascular diseases and is effective for treating hyperlipidemia. It particularly reduces the risk of myocardial infarction, stroke, and vascular interventions in patients with risk factors for coronary heart disease or those with type 2 diabetes, as well as lowers the risk of angina and hospitalizations due to congestive heart failure. Additionally, it is used to improve cholesterol and triglyceride levels in patients with dyslipidemia. Thus, this medication aids in managing blood pressure, cardiovascular diseases, and lipid disorders simultaneously.

Dosage and Administration

Adult dosage

Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.

Precautions

This medication may cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, It must be stopped immediately upon confirmation of pregnancy. In cases where muscle-related diseases are suspected or muscle enzyme levels are elevated, it may be necessary to stop taking atorvastatin, one of the components of this medication. Patients with hypersensitivity or certain liver or kidney diseases, as well as pregnant or breastfeeding women, should not take this medication. Patients with low body sodium or fluids may experience hypotension, so their condition should be carefully assessed before administration, and they should follow their doctor's instructions. Patients with high potassium levels in the blood should exercise caution when taking this medication with drugs that increase potassium, and regular blood tests should be conducted. Patients with poor kidney function, kidney transplant patients, or those who have had heart failure or myocardial infarction should take special care when taking this medication. This medication requires dose adjustments in patients with impaired liver function, and immediate consultation with a physician is needed if symptoms of liver function abnormality appear. During treatment, dizziness or fatigue may occur, so caution should be exercised while driving or operating machinery. If symptoms such as muscle pain, weakness, or fever appear during treatment, notify a physician immediately and undergo muscle enzyme testing if necessary. Since there may be interactions with other medications, it is essential to inform the physician or pharmacist of any other medications being taken. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraceptive methods. Children or patients under 18 years of age should ideally avoid its use since safety and efficacy have not been established. Elderly patients may react more sensitively to this medication, so caution should be taken to start with a lower dose and gradually increase it. It is essential to have regular liver and kidney function tests following administration, and seek immediate consultation with a specialist if any abnormal symptoms occur.

Side effects

  • Dry eyes
  • nausea
  • headache
  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • dizziness
  • drowsiness
Show 178 more
  • positional dizziness
  • sensory disturbances
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • sweating
  • itching
  • joint swelling
  • back pain
  • arthritis
  • muscle cramps
  • lethargy
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • pitting edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • taste disturbances
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • serum sickness
  • vesicular dermatitis
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • weakness
  • malaise
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • anorexia
  • abdominal bloating
  • belching
  • pharyngeal and laryngeal pain
  • epistaxis
  • nightmares
  • perceptual disturbances
  • amnesia
  • peripheral neuropathy
  • tinnitus
  • hearing loss
  • angioedema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leucocytes
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • tinnitus
  • urticaria
  • skin rash
  • alopecia
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • impotence
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • cerebral infarction
  • palpitations
  • tachycardia
  • liver dysfunction
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • anaphylaxis
  • elevated serum potassium
  • vasculitis
  • angioedema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.